BIO-UV Group S.A. (EPA:ALTUV)

Market Cap	19.16M -29.1%
Revenue (ttm)	36.87M -4.7%
Net Income	836.34K +2,566.8%
EPS	0.06 +1,903.9%
Shares Out	13.59M
PE Ratio	23.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,099
Open	1.410
Previous Close	1.410
Day's Range	1.390 - 1.420
52-Week Range	1.216 - 2.120
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 18, 2026

About BIO-UV Group

BIO-UV Group S.A. designs, manufactures, and markets water treatment and disinfectant systems using ultraviolet, salt electrolysis, ozone, and advanced oxidation for individuals and professionals in France, rest of Europe, Asia, the Middle East, the Americas, and internationally. It operates through Products, Solutions, and After-Sales divisions. The company offers disinfection equipment and systems under the triogen, AKERON, 1001 Electrodes, and BIOSEA brands; spare parts; and commissioning services. It also provides maintenance services compr...

• Industry: Pollution & Treatment Controls
• Sector: Industrials
• Founded: 2000
• Employees: 147
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTUV

Financial Performance

In 2025, BIO-UV Group's revenue was 36.87 million, a decrease of -4.69% compared to the previous year's 38.69 million. Earnings were 836,336, an increase of 2566.80%.